These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18063380)

  • 1. Response to "the effect of aspartame on the acetylcholinesterase activity in hippocampal homogenates of suckling rats" by Simintzi et al.
    Abegaz EG; Bursey RG
    Pharmacol Res; 2008 Jan; 57(1):87-8; author reply 89-90. PubMed ID: 18063380
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of aspartame on acetylcholinesterase activity in hippocampal homogenates of suckling rats.
    Simintzi I; Schulpis KH; Angelogianni P; Liapi C; Tsakiris S
    Pharmacol Res; 2007 Aug; 56(2):155-9. PubMed ID: 17580119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: The effect of aspartame metabolites on the suckling rat frontal cortex acetylcholinesterase. An in vitro study.
    Renwick AG
    Food Chem Toxicol; 2008 Mar; 46(3):1206-7; author reply 1208-9. PubMed ID: 18061330
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of aspartame metabolites on the suckling rat frontal cortex acetylcholinesterase. An in vitro study.
    Simintzi I; Schulpis KH; Angelogianni P; Liapi C; Tsakiris S
    Food Chem Toxicol; 2007 Dec; 45(12):2397-401. PubMed ID: 17673349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspartame not linked to cancer.
    Abegaz EG
    Environ Health Perspect; 2007 Jan; 115(1):A16-7; author reply A17. PubMed ID: 17366802
    [No Abstract]   [Full Text] [Related]  

  • 6. Antioxidant and acetylcholinesterase response to repeated malathion exposure in rat cerebral cortex and hippocampus.
    Trevisan R; Uliano-Silva M; Pandolfo P; Franco JL; Brocardo PS; Santos AR; Farina M; Rodrigues AL; Takahashi RN; Dafre AL
    Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):365-9. PubMed ID: 18341513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sweetening agents: saccharin--cyclamate and its metabolites--aspartame].
    Lederer J
    Rev Med Suisse Romande; 1980 Jan; 100(1):87-100. PubMed ID: 6770435
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Aspartame as a sweetener.
    Olney JW
    N Engl J Med; 1975 Jun; 292(23):1244-5. PubMed ID: 1128585
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sweetening agent aspartame as carcinogen?].
    Kinderkrankenschwester; 2006 Feb; 25(2):82. PubMed ID: 16604954
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspartame and Risk of Cancer: A Meta-analytic Review.
    Mallikarjun S; Sieburth RM
    Arch Environ Occup Health; 2015; 70(3):133-41. PubMed ID: 24965331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-junctional effects of oximes on [3H]-acetylcholine release in rat hippocampal slices during soman intoxication.
    Øydvin OK; Tansø R; Aas P
    Eur J Pharmacol; 2005 Jun; 516(3):227-34. PubMed ID: 15967427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sour finding on popular sweetener.
    Mead MN
    Environ Health Perspect; 2006 Mar; 114(3):A176. PubMed ID: 16528837
    [No Abstract]   [Full Text] [Related]  

  • 13. Astrogliosis and decreased neural viability as consequences of early consumption of aspartame and acesulfame potassium in male Wistar rats.
    Solis-Medina A; Martínez-Magaña JJ; Quintanar-Jurado V; Gallegos-Silva I; Juárez-Rojop IE; Tovilla-Zárate CA; Díaz-Zagoya JC; Hernández-Díaz Y; González-Castro TB; López-Narváez ML; Genis-Mendoza AD; Nicolini H
    Metab Brain Dis; 2018 Dec; 33(6):2031-2038. PubMed ID: 30264280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term consumption of aspartame and brain antioxidant defense status.
    Abhilash M; Sauganth Paul MV; Varghese MV; Nair RH
    Drug Chem Toxicol; 2013 Apr; 36(2):135-40. PubMed ID: 22385158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspartame-induced apoptosis in PC12 cells.
    Horio Y; Sun Y; Liu C; Saito T; Kurasaki M
    Environ Toxicol Pharmacol; 2014 Jan; 37(1):158-65. PubMed ID: 24355796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose and time dependent ototoxicity of aspartame in rats.
    Ozturan O; Dogan R; Tugrul S; Gedik O; Sjostrand AP; Yildirim YS
    Acta Otolaryngol; 2017 Apr; 137(4):421-425. PubMed ID: 27900890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxic Effect of Aspartame as an Artificial Sweetener: a Brief Review.
    Ardalan MR; Tabibi H; Ebrahimzadeh Attari V; Malek Mahdavi A
    Iran J Kidney Dis; 2017 Oct; 11(5):339-343. PubMed ID: 29038387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurotoxicity of parathion-induced acetylcholinesterase inhibition in neonatal rats.
    Veronesi B; Pope C
    Neurotoxicology; 1990; 11(3):465-82. PubMed ID: 2284052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type of cell death and the role of acetylcholinesterase activity in neurotoxicity induced by paraoxon in cultured rat hippocampal neurons.
    Bahrami F; Yousefpour M; Mehrani H; Golmanesh L; Sadraee SH; Khoshbaten A; Asgari A
    Acta Biol Hung; 2009 Mar; 60(1):1-13. PubMed ID: 19378919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies.
    Magnuson BA; Burdock GA; Doull J; Kroes RM; Marsh GM; Pariza MW; Spencer PS; Waddell WJ; Walker R; Williams GM
    Crit Rev Toxicol; 2007; 37(8):629-727. PubMed ID: 17828671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.